Journal of Vaccine Research 2024, Vol.14, No.6, 297-306 http://medscipublisher.com/index.php/jvr 305 Johansson B., Moran T., Bona C., and Kilbourne E., 1987, Immunologic response to influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. III. Reduced generation of neuraminidase-specific helper T cells in hemagglutinin-primed mice, Journal of Immunology, 139(6): 2015-2019. https://doi.org/10.4049/jimmunol.139.6.2015 Kong H., Choi Y., Kim E., and Chang J., 2023, Vaccine strategy that enhances the protective efficacy of systemic immunization by establishing lung-resident memory CD8 T cells against influenza infection, Immune Network, 23: e32. https://doi.org/10.4110/in.2023.23.e32 Laidlaw B., Zhang N., Marshall H., Staron M., Guan T., Hu Y., Cauley L., Craft J., and Kaech S., 2014, CD4+ T cell help guides formation of CD103+ lung-resident memory CD8+ T cells during influenza viral infection, Immunity, 41(4): 633-645. https://doi.org/10.1016/j.immuni.2014.09.007 Landry N., Pillet S., Favre D., Poulin J., Trépanier S., Yassine-Diab B., and Ward B., 2014, Influenza virus-like particle vaccines made in Nicotiana benthamiana elicit durable, poly-functional and cross-reactive T cell responses to influenza HA antigens, Clinical Immunology, 154(2): 164-177. https://doi.org/10.1016/j.clim.2014.08.003 Lapuente D., Bonsmann S., Maaske A., Stab V., Heinecke V., Watzstedt K., Hess R., Westendorf A., Bayer W., Ehrhardt C., and Tenbusch M., 2018, IL-1β as mucosal vaccine adjuvant: the specific induction of tissue-resident memory T cells improves the heterosubtypic immunity against influenza A viruses, Mucosal Immunology, 11: 1265-1278. https://doi.org/10.1038/s41385-018-0017-4 Lee Y., Lee Y., Kim M., Gewirtz A., and Kang S., 2016, A novel vaccination strategy mediating the induction of lung-resident memory CD8 T cells confers heterosubtypic immunity against future pandemic influenza virus, The Journal of Immunology, 196: 2637-2645. https://doi.org/10.4049/jimmunol.1501637 Li J., Arévalo M., Chen Y., Chen S., and Zeng M., 2014, T-cell-mediated cross-strain protective immunity elicited by prime-boost vaccination with a live attenuated influenza vaccine, International Journal of Infectious Diseases, 27: 37-43. https://doi.org/10.1016/j.ijid.2014.05.016 Li X., Miao H., Henn A., Topham D., Wu H., Zand M., and Mosmann T., 2012, Ki-67 expression reveals strong, transient influenza specific CD4 T cell responses after adult vaccination, Vaccine, 30(31): 4581-4584. https://doi.org/10.1016/j.vaccine.2012.04.059 Liu X., Zhao T., Wang L., Li M., Sun C., and Shu Y., 2022, Strategies targeting hemagglutinin cocktail as a potential universal influenza vaccine, Frontiers in Microbiology, 13: 1014122. https://doi.org/10.3389/fmicb.2022.1014122 Lo C., Misplon J., Li X., Price G., Ye Z., and Epstein S., 2021, Universal influenza vaccine based on conserved antigens provides long-term durability of immune responses and durable broad protection against diverse challenge virus strains in mice, Vaccine, 39(34): 4924-4933. https://doi.org/10.1016/j.vaccine.2021.06.072 Misplon J., Lo C., Crabbs T., Price G., and Epstein S., 2023, Adenoviral-vectored universal influenza vaccines administered intranasally reduce lung inflammatory responses upon viral challenge 15 months post-vaccination, Journal of Virology, 97(8): e00674-23. https://doi.org/10.1128/jvi.00674-23 Moraes V., Souquette A., and Ross T., 2023, Pre-existing T cell immune response specific to computationally optimized broadly reactive hemagglutinin antigens (COBRA-HA) in influenza vaccinees, The Journal of Immunology, 210(1): 141. https://doi.org/10.4049/jimmunol.210.supp.141.09 Nelson S., Dileepan T., Rasley A., Jenkins M., Fischer N., and Sant A., 2021, Intranasal nanoparticle vaccination elicits a persistent, polyfunctional CD4 T cell response in the murine lung specific for a highly conserved influenza virus antigen that is sufficient to mediate protection from influenza virus challenge, Journal of Virology, 95(20): e00841-21. https://doi.org/10.1128/JVI.00841-21 Oftung F., Næss L., Laake I., Stoloff G., and Pleguezuelos O., 2022, FLU-v, a broad-spectrum influenza vaccine, induces cross-reactive cellular immune responses in humans measured by dual IFN-γ and granzyme B ELISpot assay, Vaccines, 10(9): 1528. https://doi.org/10.3390/vaccines10091528 Powers D., Mcelhaney J., Florendo O., Manning M., Upshaw C., Bentley D., and Wilkinson B., 1997, Humoral and cellular immune responses following vaccination with purified recombinant hemagglutinin from influenza A (H3N2) virus, The Journal of Infectious Diseases, 175(2): 342-351. https://doi.org/10.1093/infdis/175.2.342 Sant A., Richards K., and Nayak J., 2018, Distinct and complementary roles of CD4 T cells in protective immunity to influenza virus, Current Opinion in Immunology, 53: 13-21. https://doi.org/10.1016/j.coi.2018.03.019 PMid: 29605955 Savic M., Dembinski J., Kim Y., Tunheim G., Cox R., Oftung F., Peters B., and Mjaaland S., 2016, Epitope specific T‐cell responses against influenza A in a healthy population, Immunology, 147(2): 131-142. https://doi.org/10.1111/imm.12548 Schmidt A., and Lapuente D., 2021, T cell immunity against influenza: the long way from animal models towards a real-life universal flu vaccine, Viruses, 13(2): 199. https://doi.org/10.3390/v13020199
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==